The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Spine Biologics Market Research Report 2025

Global Spine Biologics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1409254

No of Pages : 94

Ask Your Query

Synopsis

Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.

The global Spine Biologics market was valued at US$ 2363 million in 2023 and is anticipated to reach US$ 2974 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

Global Spine Biologics key players include Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, etc. Global top five manufacturers hold a share over 75%.

North America is the largest market, with a share over 60%, followed by Europe and Asia (Ex. China), both have a share about 30%.

In terms of product, Bone Graft is the largest segment, with a share over 55%. And in terms of application, the largest application is Posterior Lumbar Interbody Fusion, followed by Anterior Cervical Discectomy and Fusion, etc.

This report aims to provide a comprehensive presentation of the global market for Spine Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spine Biologics.

Report Scope

The Spine Biologics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Spine Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Spine Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Medtronic
  • Depuy Synthes
  • Stryker Corporation
  • Nuvasive
  • Zimmer Biomet
  • Orthofix International
  • Globus Medical
  • alphatec spine
  • K2M
  • Exactech
  • Wright Medical Technology
  • X-Spine
  • Nutech
  • Arthrex

Segment by Type

  • Bone Graft
  • Bone Graft Substitute
  • Platelet Rich Plasma (PRP)
  • BMAC (Bone Marrow Aspirate Concentrate)

Segment by Application

  • Anterior Cervical Discectomy and Fusion
  • Posterior Lumbar Interbody Fusion
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Spine Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Spine Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Spine Biologics Market Overview
1.1 Product Overview and Scope of Spine Biologics
1.2 Spine Biologics Segment by Type
1.2.1 Global Spine Biologics Market Value Comparison by Type (2024-2030)
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 BMAC (Bone Marrow Aspirate Concentrate)
1.3 Spine Biologics Segment by Application
1.3.1 Global Spine Biologics Market Value by Application: (2024-2030)
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.3.4 Others
1.4 Global Spine Biologics Market Size Estimates and Forecasts
1.4.1 Global Spine Biologics Revenue 2019-2030
1.4.2 Global Spine Biologics Sales 2019-2030
1.4.3 Global Spine Biologics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Spine Biologics Market Competition by Manufacturers
2.1 Global Spine Biologics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Spine Biologics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Spine Biologics Average Price by Manufacturers (2019-2024)
2.4 Global Spine Biologics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Spine Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Spine Biologics, Product Type & Application
2.7 Spine Biologics Market Competitive Situation and Trends
2.7.1 Spine Biologics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Spine Biologics Players Market Share by Revenue
2.7.3 Global Spine Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Spine Biologics Retrospective Market Scenario by Region
3.1 Global Spine Biologics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Spine Biologics Global Spine Biologics Sales by Region: 2019-2030
3.2.1 Global Spine Biologics Sales by Region: 2019-2024
3.2.2 Global Spine Biologics Sales by Region: 2025-2030
3.3 Global Spine Biologics Global Spine Biologics Revenue by Region: 2019-2030
3.3.1 Global Spine Biologics Revenue by Region: 2019-2024
3.3.2 Global Spine Biologics Revenue by Region: 2025-2030
3.4 North America Spine Biologics Market Facts & Figures by Country
3.4.1 North America Spine Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Spine Biologics Sales by Country (2019-2030)
3.4.3 North America Spine Biologics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Spine Biologics Market Facts & Figures by Country
3.5.1 Europe Spine Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Spine Biologics Sales by Country (2019-2030)
3.5.3 Europe Spine Biologics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Spine Biologics Market Facts & Figures by Country
3.6.1 Asia Pacific Spine Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Spine Biologics Sales by Country (2019-2030)
3.6.3 Asia Pacific Spine Biologics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Spine Biologics Market Facts & Figures by Country
3.7.1 Latin America Spine Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Spine Biologics Sales by Country (2019-2030)
3.7.3 Latin America Spine Biologics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Spine Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Spine Biologics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Spine Biologics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Spine Biologics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Spine Biologics Sales by Type (2019-2030)
4.1.1 Global Spine Biologics Sales by Type (2019-2024)
4.1.2 Global Spine Biologics Sales by Type (2025-2030)
4.1.3 Global Spine Biologics Sales Market Share by Type (2019-2030)
4.2 Global Spine Biologics Revenue by Type (2019-2030)
4.2.1 Global Spine Biologics Revenue by Type (2019-2024)
4.2.2 Global Spine Biologics Revenue by Type (2025-2030)
4.2.3 Global Spine Biologics Revenue Market Share by Type (2019-2030)
4.3 Global Spine Biologics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Spine Biologics Sales by Application (2019-2030)
5.1.1 Global Spine Biologics Sales by Application (2019-2024)
5.1.2 Global Spine Biologics Sales by Application (2025-2030)
5.1.3 Global Spine Biologics Sales Market Share by Application (2019-2030)
5.2 Global Spine Biologics Revenue by Application (2019-2030)
5.2.1 Global Spine Biologics Revenue by Application (2019-2024)
5.2.2 Global Spine Biologics Revenue by Application (2025-2030)
5.2.3 Global Spine Biologics Revenue Market Share by Application (2019-2030)
5.3 Global Spine Biologics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Spine Biologics Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Depuy Synthes
6.2.1 Depuy Synthes Corporation Information
6.2.2 Depuy Synthes Description and Business Overview
6.2.3 Depuy Synthes Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Depuy Synthes Spine Biologics Product Portfolio
6.2.5 Depuy Synthes Recent Developments/Updates
6.3 Stryker Corporation
6.3.1 Stryker Corporation Corporation Information
6.3.2 Stryker Corporation Description and Business Overview
6.3.3 Stryker Corporation Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Stryker Corporation Spine Biologics Product Portfolio
6.3.5 Stryker Corporation Recent Developments/Updates
6.4 Nuvasive
6.4.1 Nuvasive Corporation Information
6.4.2 Nuvasive Description and Business Overview
6.4.3 Nuvasive Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nuvasive Spine Biologics Product Portfolio
6.4.5 Nuvasive Recent Developments/Updates
6.5 Zimmer Biomet
6.5.1 Zimmer Biomet Corporation Information
6.5.2 Zimmer Biomet Description and Business Overview
6.5.3 Zimmer Biomet Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zimmer Biomet Spine Biologics Product Portfolio
6.5.5 Zimmer Biomet Recent Developments/Updates
6.6 Orthofix International
6.6.1 Orthofix International Corporation Information
6.6.2 Orthofix International Description and Business Overview
6.6.3 Orthofix International Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Orthofix International Spine Biologics Product Portfolio
6.6.5 Orthofix International Recent Developments/Updates
6.7 Globus Medical
6.6.1 Globus Medical Corporation Information
6.6.2 Globus Medical Description and Business Overview
6.6.3 Globus Medical Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Globus Medical Spine Biologics Product Portfolio
6.7.5 Globus Medical Recent Developments/Updates
6.8 alphatec spine
6.8.1 alphatec spine Corporation Information
6.8.2 alphatec spine Description and Business Overview
6.8.3 alphatec spine Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 alphatec spine Spine Biologics Product Portfolio
6.8.5 alphatec spine Recent Developments/Updates
6.9 K2M
6.9.1 K2M Corporation Information
6.9.2 K2M Description and Business Overview
6.9.3 K2M Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 K2M Spine Biologics Product Portfolio
6.9.5 K2M Recent Developments/Updates
6.10 Exactech
6.10.1 Exactech Corporation Information
6.10.2 Exactech Description and Business Overview
6.10.3 Exactech Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Exactech Spine Biologics Product Portfolio
6.10.5 Exactech Recent Developments/Updates
6.11 Wright Medical Technology
6.11.1 Wright Medical Technology Corporation Information
6.11.2 Wright Medical Technology Spine Biologics Description and Business Overview
6.11.3 Wright Medical Technology Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Wright Medical Technology Spine Biologics Product Portfolio
6.11.5 Wright Medical Technology Recent Developments/Updates
6.12 X-Spine
6.12.1 X-Spine Corporation Information
6.12.2 X-Spine Spine Biologics Description and Business Overview
6.12.3 X-Spine Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 X-Spine Spine Biologics Product Portfolio
6.12.5 X-Spine Recent Developments/Updates
6.13 Nutech
6.13.1 Nutech Corporation Information
6.13.2 Nutech Spine Biologics Description and Business Overview
6.13.3 Nutech Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Nutech Spine Biologics Product Portfolio
6.13.5 Nutech Recent Developments/Updates
6.14 Arthrex
6.14.1 Arthrex Corporation Information
6.14.2 Arthrex Spine Biologics Description and Business Overview
6.14.3 Arthrex Spine Biologics Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Arthrex Spine Biologics Product Portfolio
6.14.5 Arthrex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Spine Biologics Industry Chain Analysis
7.2 Spine Biologics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Spine Biologics Production Mode & Process
7.4 Spine Biologics Sales and Marketing
7.4.1 Spine Biologics Sales Channels
7.4.2 Spine Biologics Distributors
7.5 Spine Biologics Customers
8 Spine Biologics Market Dynamics
8.1 Spine Biologics Industry Trends
8.2 Spine Biologics Market Drivers
8.3 Spine Biologics Market Challenges
8.4 Spine Biologics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock